Bimoclomol protects against vascular consequences of experimental subarachnoid hemorrhage in rats.
Bimoclomol (BRLP-42) is a novel antiischemic compound acting against peripheral vascular complications of diabetes mellitus (neuropathy, retinopathy, and nephropathy). In the present study the activity of bimoclomol was tested in experimental subarachnoid hemorrhage (SAH) and arachidonic acid (AA)-i...
Main Authors: | |
---|---|
Format: | Article |
Published: |
1998
|
Series: | BRAIN RESEARCH BULLETIN
45 No. 2 |
Subjects: | |
doi: | 10.1016/S0361-9230(97)00333-X |
mtmt: | 2802864 |
Online Access: | https://publikacio.ppke.hu/2337 |